Editorial comment

Can J Urol. 2010 Jun;17(3):5169.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adenocarcinoma / blood*
  • Adenocarcinoma / drug therapy*
  • Antineoplastic Agents, Hormonal / administration & dosage
  • Finasteride / therapeutic use*
  • Humans
  • Male
  • Prostate-Specific Antigen / blood*
  • Prostate-Specific Antigen / drug effects*
  • Prostatic Neoplasms / blood*
  • Prostatic Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents, Hormonal
  • Finasteride
  • Prostate-Specific Antigen